The investment seeks to replicate investment results that generally correspond, before fees and expenses, to the performance of the Inspire Corporate Bond Index... Show more
A.I.dvisor indicates that over the last year, IBD has been loosely correlated with SCHI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IBD jumps, then SCHI could also see price increases.
| Ticker / NAME | Correlation To IBD | 1D Price Change % | ||
|---|---|---|---|---|
| IBD | 100% | +0.17% | ||
| SCHI - IBD | 56% Loosely correlated | -0.14% | ||
| SPBO - IBD | 56% Loosely correlated | -0.07% | ||
| SPIB - IBD | 55% Loosely correlated | N/A | ||
| LQD - IBD | 53% Loosely correlated | -0.10% | ||
| USIG - IBD | -5% Poorly correlated | -0.08% | ||
More | ||||
Category IntermediateTermBond
The Moving Average Convergence Divergence (MACD) for IBD turned positive on October 07, 2026. Looking at past instances where IBD's MACD turned positive, the stock continued to rise in 39 of 55 cases over the following month. The odds of a continued upward trend are 71%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IBD's RSI Indicator exited the oversold zone, 15 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 29 of 51 cases where IBD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on IBD as a result. In 64 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
Following a +0.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBD advanced for three days, in 163 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
IBD broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IBD entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.